LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Health & Fitness
• Education
• Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure how the site profits.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

article, google, scholar, pubmed, endothelial, patients, pentraxin, candesartan, dysfunction, cas, hypertension, study, blockers, ptx, levels, hypertensive, central, angiotensin, effect, andor, inflammatory, hscrp, cardiovascular, receptor, plasma, inflammation, biomarkers, antihypertensive, disease, pharmacy, timisoara, romania, privacy, cookies, content, data, journal, medical, marker, buda, cristescu, biomarker, protein, markers, vascular, access, cardiol, sci, type, effects,

Topics {✒️}

p-selectin/matrix metalloproteinase-1 pathway grant pii-c4-tc-2016-16441-09 offered high-selectivity c-reactive protein high-sensitivity c-reactive protein high-sensitive c-reactive protein month download article/chapter essential arterial hypertension renin–angiotensin–aldosterone syst hs-crp plasma levels angiotensin receptor blockers c-reactive protein article irish journal renin–angiotensin system full article pdf privacy choices/manage cookies institutional research committee treating resistant hypertension type-2 diabetic patients biochemical markers blood pressure levels acute coronary syndrome european economic area calcium channel blockers elevated pentraxin-3 levels ptx3 plasma levels coronary artery disease endothelial dysfunction confirmed reversing endothelial dysfunction pentraxin-3 plasma levels �victor babes” university scope submit manuscript normal ejection fraction martin-ventura jl flow-mediated dilatation inflammatory cardiovascular disease conditions privacy policy related subjects essential cookies article buda electronic medical records higher vascular protection endothelial dysfunction—methods early cognitive impairment predicting cognitive impairment journal finder publish accepting optional cookies evaluating endothelial function multi-ethnic study retrospective longitudinal survey markers

Schema {🗺️}

WebPage:
      mainEntity:
         headline:The effect of candesartan on pentraxin-3 plasma levels as marker of endothelial dysfunction in patients with essential arterial hypertension
         description:In the last decades, the studies performed on the field of endothelial dysfunction confirmed the fact that the starting point of this pathology is the inflammation. Several inflammatory biomarkers had been discovered and studied, ones showing systemic inflammation, and others being more specific biomarkers and showing the local inflammation. Pentraxin-3 (PTX3) is a new inflammatory biomarker, from the same family as high-selectivity C-reactive protein (hs-CRP), but it is a more specific biomarker, due to its local production: the endothelial cells and not the liver like in the case of hs-CRP. Several antihypertensive classes of drugs seem to have a positive impact on reducing the local endothelial inflammation, beyond their effect of lowering the blood pressure, so this study aims to analyze the effect of candesartan on the two inflammatory biomarkers: PTX3 and CRP, compared with other antihypertensive drugs, in hypertensive patients with endothelial dysfunction. A total of 365 patients were included in the study: 127 hypertensive patients were under treatment with candesartan, 134 patients were under treatment with other hypotensive medication (beta blockers, calcium channel blockers, and diuretics), both groups with controlled values of blood pressure, and 104 were normotensive persons. Classical methods of assessing the endothelial function were correlated with these biochemical markers. The patients treated with candesartan had a significant lower value of PTX3 and hs-CRP, compared with those under treatment with other antihypertensive medication as follows: PTX3: 0.61 ± 0.49 vs 0.95 ± 1.04 ng/ml, P = 0.006 and hs-CRP: 0.19 ± 0.20 vs 0.20 ± 0.22 mg/dl, P = 0.54. Candesartan decreases PTX3 and hs-CRP plasma levels more powerful than other classes of antihypertensive drugs (beta blockers, calcium channel blockers, and diuretics), so we may assume that candesartan has a more potent action in reversing endothelial dysfunction and that it offers a higher vascular protection than other classes of antihypertensive drugs. We are suggesting that this new biochemical marker, PTX3, might be better and more specific marker for endothelial dysfunction, than hs-CRP.
         datePublished:2017-02-21T00:00:00Z
         dateModified:2017-02-21T00:00:00Z
         pageStart:621
         pageEnd:629
         sameAs:https://doi.org/10.1007/s11845-017-1580-5
         keywords:
            Candesartan
            Pentraxin-3
            PTX3
            Endothelial dysfunction
            hs-CRP
            Essential arterial hypertension
            Internal Medicine
            General Practice / Family Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11845-017-1580-5/MediaObjects/11845_2017_1580_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11845-017-1580-5/MediaObjects/11845_2017_1580_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11845-017-1580-5/MediaObjects/11845_2017_1580_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11845-017-1580-5/MediaObjects/11845_2017_1580_Fig4_HTML.gif
         isPartOf:
            name:Irish Journal of Medical Science (1971 -)
            issn:
               1863-4362
               0021-1265
            volumeNumber:186
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer London
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:V. Buda
               affiliation:
                     name:“Victor Babes” University of Medicine and Pharmacy Timişoara
                     address:
                        name:Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
                        type:PostalAddress
                     type:Organization
               type:Person
               name:M. Andor
               affiliation:
                     name:“Victor Babes” University of Medicine and Pharmacy Timişoara
                     address:
                        name:Department of Medical Semiotics, Faculty of Medicine, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:C. Cristescu
               affiliation:
                     name:“Victor Babes” University of Medicine and Pharmacy Timişoara
                     address:
                        name:Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
                        type:PostalAddress
                     type:Organization
               type:Person
               name:M. Voicu
               affiliation:
                     name:“Victor Babes” University of Medicine and Pharmacy Timişoara
                     address:
                        name:Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
                        type:PostalAddress
                     type:Organization
               type:Person
               name:F. Cochera
               affiliation:
                     name:“Victor Babes” University of Medicine and Pharmacy Timişoara
                     address:
                        name:Department of Medical Semiotics, Faculty of Medicine, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
                        type:PostalAddress
                     type:Organization
               type:Person
               name:P. Tuduce
               affiliation:
                     name:“Vasile Goldis” Western University
                     address:
                        name:Department of Balneophysiotherapy, Rheumatology and Rehabilitation, “Vasile Goldis” Western University, Arad, Romania
                        type:PostalAddress
                     type:Organization
               type:Person
               name:L. Petrescu
               affiliation:
                     name:Cardiovascular Diseases Institute of Timisoara
                     address:
                        name:Cardiovascular Diseases Institute of Timisoara, Timisoara, Romania
                        type:PostalAddress
                     type:Organization
               type:Person
               name:M. C. Tomescu
               affiliation:
                     name:“Victor Babes” University of Medicine and Pharmacy Timişoara
                     address:
                        name:Department of Medical Semiotics, Faculty of Medicine, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The effect of candesartan on pentraxin-3 plasma levels as marker of endothelial dysfunction in patients with essential arterial hypertension
      description:In the last decades, the studies performed on the field of endothelial dysfunction confirmed the fact that the starting point of this pathology is the inflammation. Several inflammatory biomarkers had been discovered and studied, ones showing systemic inflammation, and others being more specific biomarkers and showing the local inflammation. Pentraxin-3 (PTX3) is a new inflammatory biomarker, from the same family as high-selectivity C-reactive protein (hs-CRP), but it is a more specific biomarker, due to its local production: the endothelial cells and not the liver like in the case of hs-CRP. Several antihypertensive classes of drugs seem to have a positive impact on reducing the local endothelial inflammation, beyond their effect of lowering the blood pressure, so this study aims to analyze the effect of candesartan on the two inflammatory biomarkers: PTX3 and CRP, compared with other antihypertensive drugs, in hypertensive patients with endothelial dysfunction. A total of 365 patients were included in the study: 127 hypertensive patients were under treatment with candesartan, 134 patients were under treatment with other hypotensive medication (beta blockers, calcium channel blockers, and diuretics), both groups with controlled values of blood pressure, and 104 were normotensive persons. Classical methods of assessing the endothelial function were correlated with these biochemical markers. The patients treated with candesartan had a significant lower value of PTX3 and hs-CRP, compared with those under treatment with other antihypertensive medication as follows: PTX3: 0.61 ± 0.49 vs 0.95 ± 1.04 ng/ml, P = 0.006 and hs-CRP: 0.19 ± 0.20 vs 0.20 ± 0.22 mg/dl, P = 0.54. Candesartan decreases PTX3 and hs-CRP plasma levels more powerful than other classes of antihypertensive drugs (beta blockers, calcium channel blockers, and diuretics), so we may assume that candesartan has a more potent action in reversing endothelial dysfunction and that it offers a higher vascular protection than other classes of antihypertensive drugs. We are suggesting that this new biochemical marker, PTX3, might be better and more specific marker for endothelial dysfunction, than hs-CRP.
      datePublished:2017-02-21T00:00:00Z
      dateModified:2017-02-21T00:00:00Z
      pageStart:621
      pageEnd:629
      sameAs:https://doi.org/10.1007/s11845-017-1580-5
      keywords:
         Candesartan
         Pentraxin-3
         PTX3
         Endothelial dysfunction
         hs-CRP
         Essential arterial hypertension
         Internal Medicine
         General Practice / Family Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11845-017-1580-5/MediaObjects/11845_2017_1580_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11845-017-1580-5/MediaObjects/11845_2017_1580_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11845-017-1580-5/MediaObjects/11845_2017_1580_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11845-017-1580-5/MediaObjects/11845_2017_1580_Fig4_HTML.gif
      isPartOf:
         name:Irish Journal of Medical Science (1971 -)
         issn:
            1863-4362
            0021-1265
         volumeNumber:186
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer London
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:V. Buda
            affiliation:
                  name:“Victor Babes” University of Medicine and Pharmacy Timişoara
                  address:
                     name:Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
                     type:PostalAddress
                  type:Organization
            type:Person
            name:M. Andor
            affiliation:
                  name:“Victor Babes” University of Medicine and Pharmacy Timişoara
                  address:
                     name:Department of Medical Semiotics, Faculty of Medicine, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:C. Cristescu
            affiliation:
                  name:“Victor Babes” University of Medicine and Pharmacy Timişoara
                  address:
                     name:Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
                     type:PostalAddress
                  type:Organization
            type:Person
            name:M. Voicu
            affiliation:
                  name:“Victor Babes” University of Medicine and Pharmacy Timişoara
                  address:
                     name:Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
                     type:PostalAddress
                  type:Organization
            type:Person
            name:F. Cochera
            affiliation:
                  name:“Victor Babes” University of Medicine and Pharmacy Timişoara
                  address:
                     name:Department of Medical Semiotics, Faculty of Medicine, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
                     type:PostalAddress
                  type:Organization
            type:Person
            name:P. Tuduce
            affiliation:
                  name:“Vasile Goldis” Western University
                  address:
                     name:Department of Balneophysiotherapy, Rheumatology and Rehabilitation, “Vasile Goldis” Western University, Arad, Romania
                     type:PostalAddress
                  type:Organization
            type:Person
            name:L. Petrescu
            affiliation:
                  name:Cardiovascular Diseases Institute of Timisoara
                  address:
                     name:Cardiovascular Diseases Institute of Timisoara, Timisoara, Romania
                     type:PostalAddress
                  type:Organization
            type:Person
            name:M. C. Tomescu
            affiliation:
                  name:“Victor Babes” University of Medicine and Pharmacy Timişoara
                  address:
                     name:Department of Medical Semiotics, Faculty of Medicine, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Irish Journal of Medical Science (1971 -)
      issn:
         1863-4362
         0021-1265
      volumeNumber:186
Organization:
      name:Springer London
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:“Victor Babes” University of Medicine and Pharmacy Timişoara
      address:
         name:Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
         type:PostalAddress
      name:“Victor Babes” University of Medicine and Pharmacy Timişoara
      address:
         name:Department of Medical Semiotics, Faculty of Medicine, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
         type:PostalAddress
      name:“Victor Babes” University of Medicine and Pharmacy Timişoara
      address:
         name:Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
         type:PostalAddress
      name:“Victor Babes” University of Medicine and Pharmacy Timişoara
      address:
         name:Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
         type:PostalAddress
      name:“Victor Babes” University of Medicine and Pharmacy Timişoara
      address:
         name:Department of Medical Semiotics, Faculty of Medicine, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
         type:PostalAddress
      name:“Vasile Goldis” Western University
      address:
         name:Department of Balneophysiotherapy, Rheumatology and Rehabilitation, “Vasile Goldis” Western University, Arad, Romania
         type:PostalAddress
      name:Cardiovascular Diseases Institute of Timisoara
      address:
         name:Cardiovascular Diseases Institute of Timisoara, Timisoara, Romania
         type:PostalAddress
      name:“Victor Babes” University of Medicine and Pharmacy Timişoara
      address:
         name:Department of Medical Semiotics, Faculty of Medicine, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:V. Buda
      affiliation:
            name:“Victor Babes” University of Medicine and Pharmacy Timişoara
            address:
               name:Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
               type:PostalAddress
            type:Organization
      name:M. Andor
      affiliation:
            name:“Victor Babes” University of Medicine and Pharmacy Timişoara
            address:
               name:Department of Medical Semiotics, Faculty of Medicine, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:C. Cristescu
      affiliation:
            name:“Victor Babes” University of Medicine and Pharmacy Timişoara
            address:
               name:Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
               type:PostalAddress
            type:Organization
      name:M. Voicu
      affiliation:
            name:“Victor Babes” University of Medicine and Pharmacy Timişoara
            address:
               name:Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
               type:PostalAddress
            type:Organization
      name:F. Cochera
      affiliation:
            name:“Victor Babes” University of Medicine and Pharmacy Timişoara
            address:
               name:Department of Medical Semiotics, Faculty of Medicine, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
               type:PostalAddress
            type:Organization
      name:P. Tuduce
      affiliation:
            name:“Vasile Goldis” Western University
            address:
               name:Department of Balneophysiotherapy, Rheumatology and Rehabilitation, “Vasile Goldis” Western University, Arad, Romania
               type:PostalAddress
            type:Organization
      name:L. Petrescu
      affiliation:
            name:Cardiovascular Diseases Institute of Timisoara
            address:
               name:Cardiovascular Diseases Institute of Timisoara, Timisoara, Romania
               type:PostalAddress
            type:Organization
      name:M. C. Tomescu
      affiliation:
            name:“Victor Babes” University of Medicine and Pharmacy Timişoara
            address:
               name:Department of Medical Semiotics, Faculty of Medicine, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
      name:Department of Medical Semiotics, Faculty of Medicine, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
      name:Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
      name:Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
      name:Department of Medical Semiotics, Faculty of Medicine, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
      name:Department of Balneophysiotherapy, Rheumatology and Rehabilitation, “Vasile Goldis” Western University, Arad, Romania
      name:Cardiovascular Diseases Institute of Timisoara, Timisoara, Romania
      name:Department of Medical Semiotics, Faculty of Medicine, “Victor Babes” University of Medicine and Pharmacy Timişoara, Timisoara, Romania
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(123)

• Discover the revenue of https://www.springernature.com/gp/authors
• How much money does https://link.springernature.com/home/ make?
• How much does https://order.springer.com/public/cart generate monthly?
• How much revenue does https://www.editorialmanager.com/ijms produce monthly?
• Find out how much https://www.springernature.com/gp/librarians/licensing/agc/journals earns monthly
• How much does https://doi.org/10.1161%2FHYPERTENSIONAHA.114.03575 earn?
• How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25156167 have monthly?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Endothelial%20dysfunction%20and%20hypertension&journal=Hypertension&doi=10.1161%2FHYPERTENSIONAHA.114.03575&volume=64&pages=924-928&publication_year=2014&author=Brandes%2CRP generate?
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=Endothelial%20dysfunction%E2%80%94methods%20of%20assessment%20and%20pharmacological%20approach%20in%20cardiovascular%20diseases&journal=TMJ&volume=55&issue=1&pages=58-63&publication_year=2005&author=Andor%2CM&author=Tomescu%2CM
• See how much http://scholar.google.com/scholar_lookup?&title=Endothelial%20dysfunction%20and%20cardiovascular%20disease&journal=Global%20Cardiol%20Sci%20Pract&volume=2014&issue=3&pages=291-308&publication_year=2014&author=Widmer%2CRJ&author=Lerman%2CA makes per month
• How much does https://doi.org/10.1161%2F01.CIR.0000089190.95415.9F pull in monthly?
• What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14568885?
• See how much http://scholar.google.com/scholar_lookup?&title=New%20markers%20of%20inflammation%20and%20endothelial%20cell%20activation%20part%20I&journal=Circulation&doi=10.1161%2F01.CIR.0000089190.95415.9F&volume=108&pages=1917-1923&publication_year=2003&author=Szmitko%2CPE&author=Wang%2CCH&author=Weisel%2CRD makes per month
• How much does https://doi.org/10.1161%2F01.CIR.0000089093.75585.98 generate monthly?
• Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14581382
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Biomarkers%20of%20vascular%20disease%20linking%20inflammation%20to%20endothelial%20activation%20part%20II&journal=Circulation&doi=10.1161%2F01.CIR.0000089093.75585.98&volume=108&pages=2041-2048&publication_year=2003&author=Szmitko%2CPE&author=Wang%2CCH&author=Weisel%2CRD?
• How much revenue does https://doi.org/10.1093%2Fndt%2Fgfs448 bring in?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23243042 rake in every month?
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Pentraxins%20in%20nephrology%3A%20C-reactive%20protein%2C%20serum%20amyloid%20P%20and%20pentraxin-3&journal=Nephrol%20Dial%20Transplant&doi=10.1093%2Fndt%2Fgfs448&volume=28&pages=803-811&publication_year=2013&author=Lech%2CM&author=Rommele%2CC&author=Anders%2CHJ?
• Get to know https://doi.org/10.1016%2Fj.jjcc.2011.03.006's earnings
• What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21616640?
• How much money does http://scholar.google.com/scholar_lookup?&title=Pentraxin%203%20as%20a%20biomarker%20for%20acute%20coronary%20syndrome%3A%20comparison%20with%20biomarkers%20for%20cardiac%20damage&journal=J%20Cardiol&doi=10.1016%2Fj.jjcc.2011.03.006&volume=58&pages=38-45&publication_year=2011&author=Kume%2CN&author=Mitsuoka%2CH&author=Hayashida%2CK&author=Tanaka%2CM make?
• What's the total monthly financial gain of https://doi.org/10.1111%2Fjth.12557?
• How much income is http://scholar.google.com/scholar_lookup?&title=Associations%20of%20pentraxin%203%20with%20cardiovascular%20disease%3A%20the%20multi-ethnic%20study%20of%20atherosclerosis&journal=J%20Thromb%20Hemost&doi=10.1111%2Fjth.12557&volume=12&pages=999-1005&publication_year=2014&author=Jenny%2CNS&author=Blumenthal%2CRS&author=Kronmal%2CRA&author=Rotter%2CJI&author=Siscovick%2CDS&author=Psaty%2CBM earning monthly?
• How much does https://doi.org/10.1016%2Fj.jacc.2010.10.018 pull in?
• What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21310324?
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=Pentraxin%203%20is%20a%20new%20inflammatory%20marker%20correlated%20with%20left%20ventricular%20diastolic%20dysfunction%20and%20heart%20failure%20with%20normal%20ejection%20fraction&journal=J%20Am%20Coll%20Cardiol&doi=10.1016%2Fj.jacc.2010.10.018&volume=57&pages=861-869&publication_year=2011&author=Matsubara%2CJ&author=Sugiyama%2CS&author=Nozaki%2CT&author=Sugamura%2CK&author=Konishi%2CM?
• How much does https://doi.org/10.1136%2Fhrt.2003.032847 pull in?
• What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15772232?
• What's the financial gain of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1768833?
• How much profit is http://scholar.google.com/scholar_lookup?&title=Evaluating%20endothelial%20function%20in%20humans%3A%20a%20guide%20to%20invasive%20and%20non%20invasive%20techniques&journal=Heart&doi=10.1136%2Fhrt.2003.032847&volume=91&pages=553-558&publication_year=2005&author=Tousoulis%2CD&author=Antoniades%2CC&author=Stefanadic%2CC making per month?
• What's the financial intake of http://scholar.google.com/scholar_lookup?&title=A%20review%20on%20candesartan%3A%20pharmacological%20and%20pharmaceutical%20profile&journal=J%20Appl%20Pharm%20Sci&volume=10&pages=12-17&publication_year=2011&author=Husain%2CA&author=Azim%2CS&author=Mitra%2CM&author=Bhasin%2CPS?
• What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Blockers%20of%20the%20RAA%20system%3A%20perindopril%20and%20candesartan%20and%20their%20implication%20on%20endothelial%20dysfunction&journal=Med%20Evol&volume=3&pages=509-517&publication_year=2014&author=Buda%2CV&author=Andor%2CM&author=Cristescu%2CC&author=Voicu%2CM&author=Suciu%2CL&author=Suciu%2CM&author=Tomescu%2CM?
• What's the income of https://doi.org/10.1161%2F01.CIR.103.6.904?
• Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11171802
• What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Angiotensin%20II%20type%201%20receptor%20blockers&journal=Circulation&doi=10.1161%2F01.CIR.103.6.904&volume=103&pages=904-912&publication_year=2001&author=Burnier%2CM?
• What's the financial gain of https://doi.org/10.1177/1470320310370852?
• What's the revenue for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891522?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Angiotensin%20II%20type%201%20receptor%20blockers%3A%20class%20effects%20versus%20molecular%20effects&journal=J%20Renin%E2%80%93Angiotensin%E2%80%93Aldosterone%20Syst&doi=10.1177%2F1470320310370852&publication_year=2011&author=Miura%2CS&author=Karnik%2CSS&author=Saku%2CK bring in?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Use%20of%20angiotensin%20receptor%20blockers%20in%20cardiovascular%20protection&journal=Curr%20Evid%20Future%20Dir%20P%26T&volume=36&publication_year=2011&author=Munger%2CMA generate?
• What are the earnings of https://doi.org/10.1124%2Fpr.112.007278?
• Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23487168
• How much does http://scholar.google.com/scholar_lookup?&title=A%20systematic%20comparison%20of%20the%20properties%20of%20clinically%20used%20angiotensin%20II%20type%201%20receptor%20antagonists&journal=Pharmacol%20Rev&doi=10.1124%2Fpr.112.007278&volume=65&pages=809-848&publication_year=2013&author=Michel%2CMC&author=Foster%2CC&author=Brunner%2CHR&author=Liu%2CL gross monthly?
• Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19922631 earns monthly
• Monthly income for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784465
• How much money does http://scholar.google.com/scholar_lookup?&title=The%20rationale%20and%20design%20of%20the%20antihypertensives%20and%20vascular%2C%20endothelial%2C%20and%20cognitive%20function%20%28AVEC%29%20trial%20in%20elderly%20hypertensives%20with%20early%20cognitive%20impairment%3A%20role%20of%20the%20renin%20angiotensin%20system%20inhibition&journal=BMC%20Geriatr&doi=10.1186%2F1471-2318-9-48&volume=9&publication_year=2009&author=Hajjar%2CI&author=Hart%2CM&author=Milberg%2CW make?
• What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20712859?
• How much profit is http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933671 making per month?
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=Effect%20of%C2%A0candesartan%C2%A0monotherapy%20on%20lipid%20metabolism%20in%20patients%20with%20hypertension%3A%20a%20retrospective%20longitudinal%20survey%20using%20data%20from%20electronic%20medical%20records&journal=Cardiovasc%20Diabetol&doi=10.1186%2F1475-2840-9-38&volume=9&publication_year=2010&author=Nishida%2CY&author=Takahashi%2CY&author=Nakayama%2CT?
• What are the earnings of https://doi.org/10.1016%2Fj.ejphar.2006.08.062?
• What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17064684?
• What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1764497?
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Long-term%20angiotensin%20II%20AT1%20_receptor%20inhibition%20produces%20adipose%20tissue%20hypotrophy%20accompanied%20by%20increased%20expression%20of%20adiponectin%20and%20PPAR%CE%B3&journal=Eur%20J%20Pharmacol&doi=10.1016%2Fj.ejphar.2006.08.062&volume=552&pages=112-122&publication_year=2006&author=Zorad%2CS&author=Dou%2CJT&author=Benicky%2CJ&author=Hutanu%2CD?
• How much does http://scholar.google.com/scholar_lookup?&title=Telmisartan%E2%80%94killing%20two%20birds%20with%20one%20stone&journal=Pharmacotherapy&volume=5&pages=2397-2400&publication_year=2004&author=Doggrell%2CSA pull in?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17903269 make?
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2098751's financial summary
• What's the income generated by http://scholar.google.com/scholar_lookup?&title=Angiotensin%20II%20receptor%20blockers%20decreased%20blood%20glucose%20levels%3A%20a%20longitudinal%20survey%20using%20data%20from%20electronic%20medical%20records&journal=Cardiovasc%20Diabetol&doi=10.1186%2F1475-2840-6-26&volume=6&publication_year=2007&author=Kitamura%2CN&author=Takahashi%2CY&author=Yamadate%2CS&author=Asai%2CS each month?
• Revenue of https://doi.org/10.1016%2FS0735-1097%2803%2900846-5
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Pleiotropic%20effects%20of%20ang%20II%20receptor%20blocker%20in%20hypertensive%20patients&journal=J%20Am%20Coll%20Cardiol&doi=10.1016%2FS0735-1097%2803%2900846-5&volume=42&issue=5&pages=905-910&publication_year=2003&author=Kwang%2CKK&author=Jeong%2CJA
• Financial intake of https://doi.org/10.1097%2F00004872-200305000-00011
• How much revenue does http://scholar.google.com/scholar_lookup?&title=SCOPE%20study%20groups%3A%20the%20study%20on%20cognitive%20and%20prognosis%20in%20the%20elderly%3A%20principal%20results%20of%20a%20randomized%20double-blind%20interventional%20trial&journal=Hypertension&doi=10.1097%2F00004872-200305000-00011&volume=21&pages=875-886&publication_year=2003&author=Lithell%2CH&author=Hansson%2CL&author=Skoog%2CI produce monthly?
• How much money does https://doi.org/10.1161%2F01.STR.0000075777.18006.89 generate?
• What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12817109?
• How much income does http://scholar.google.com/scholar_lookup?&title=Acute%20candesartan%20cilexitil%20therapy%20in%20stroke%20survivors%20study%20group%3A%20the-ACCESS%20study%3A%20evaluation%20of%20acute%20candesartan%20cilexitil%20therapy%20in%20stroke%20survivors&journal=Stroke&doi=10.1161%2F01.STR.0000075777.18006.89&volume=34&pages=1699-1703&publication_year=2003&author=Schrader%2CJ&author=Luders%2CS&author=Kulschewski%2CA have?
• What's the monthly income of https://doi.org/10.2215%2FCJN.01110210?
• How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20430947 have monthly?
• Discover the revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893063
• What's http://scholar.google.com/scholar_lookup?&title=Combined%20therapy%20with%20renin%E2%80%93angiotensin%20system%20and%20calcium%20channel%20blockers%20in%20type%202%20diabetic%20hypertensive%20patients%20with%20proteinuria%3A%20effects%20on%20soluble%20TWEAK%2C%20PTX3%20and%20flow-mediated%20dilatation&journal=Clin%20J%20Am%20Soc%20Nephrol&doi=10.2215%2FCJN.01110210&volume=5&issue=7&pages=1174-1181&publication_year=2010&author=Yilmaz%2CMI&author=Carreo%2CJJ&author=Martin-Ventura%2CJL's gross income?
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=The%20influence%20of%20perindopril%20on%20PTX3%20plasma%20levels%20in%20hypertensive%20patients%20with%20endothelial%20dysfunction&journal=Farmacia&volume=64&issue=3&pages=382-389&publication_year=2016&author=Buda%2CV&author=Andor%2CM&author=Cristescu%2CC is on a monthly basis
• How much profit is https://doi.org/10.1093%2Fgerona%2Fglq030 making per month?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20203097 pull in monthly?
• Profit of http://scholar.google.com/scholar_lookup?&title=Plasma%20pentraxin%203%20but%20not%20high-sensitivity%20C-reactive%20protein%2C%20is%20a%20useful%20inflammatory%20biomarker%20for%20predicting%20cognitive%20impairment%20in%20elderly%20hypertensive%20patients&journal=J%20Gerontol%20A%20Biol%20Sci%20Med%20Sci&doi=10.1093%2Fgerona%2Fglq030&volume=65&issue=5&pages=547-552&publication_year=2010&author=Yano%2CY&author=Matsuda%2CS&author=Hatakeyama%2CK
• How much does https://doi.org/10.2215%2FCJN.04330808 pull in?
• Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19211665
• What's the financial outcome of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653664?
• How much money does http://scholar.google.com/scholar_lookup?&title=Effect%20of%20renin%20angiotensin%20system%20blockade%20on%20pentraxin%203%20levels%20in%20type-2%20diabetic%20patients%20with%20proteinuria&journal=Clin%20J%20Am%20Soc%20Nephrol&doi=10.2215%2FCJN.04330808&volume=4&issue=3&pages=535-541&publication_year=2009&author=Yilmaz%2CMI&author=Axelsson%2CJ&author=Sonmez%2CA make?
• Learn about the earnings of https://doi.org/10.3109%2F10641963.2012.739237
• What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23148500?
• How much money does http://scholar.google.com/scholar_lookup?&title=The%20comparative%20effects%20of%20valsartan%20and%20amlodipine%20on%20vascular%20microinflammation%20in%20newly%20diagnosed%20hypertensive%20patients&journal=Clin%20Exp%20Hypertens&doi=10.3109%2F10641963.2012.739237&volume=35&issue=6&pages=418-423&publication_year=2013&author=Unlu%2CM&author=Karaman%2CM&author=Ahmet%2CSA make?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Elevated%20pentraxin-3%20levels%20are%20related%20to%20blood%20pressure%20levels%20in%20hypertensive%20patients%3A%20an%20observational%20study&journal=Anatol%20J%20Cardiol&volume=12&issue=4&pages=298-304&publication_year=2012&author=Parlak%2CA&author=Aydogan%2CU&author=Iyisoy%2CA generate?
• How profitable is https://doi.org/10.1161/CIRCULATIONAHA?
• How much revenue does https://doi.org/10.1161%2FCIRCULATIONAHA.114.014822 bring in?
• Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25747934
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Pentraxin%203%20induces%20vascular%20endothelial%20dysfunction%20through%20a%20P-selectin%2Fmatrix%20metalloproteinase-1%20pathway&journal=Circulation&doi=10.1161%2FCIRCULATIONAHA&volume=131&issue=17&pages=1495-1505&publication_year=2015&author=Carrizzo%2CA&author=Lenzi%2CP&author=Procaccini%2CC?
• Learn how profitable https://doi.org/10.1536%2Fihj.13-253 is on a monthly basis
• Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24632958
• How much money does http://scholar.google.com/scholar_lookup?&title=Plasma%20pentraxin%203%20is%20a%20more%20potent%20predictor%20of%20endothelial%20dysfunction%20than%20high-sensitive%20C-reactive%20protein&journal=Int%20Heart%20J&doi=10.1536%2Fihj.13-253&volume=55&issue=2&pages=160-164&publication_year=2014&author=Yasunaga%2CT&author=Ikeda%2CS&author=Koga%2CS generate?
• Monthly income for https://citation-needed.springer.com/v2/references/10.1007/s11845-017-1580-5?format=refman&flavour=references
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=V.%20Buda income
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22V.%20Buda%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
• What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M.%20Andor?
• Get to know what's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M.%20Andor%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=C.%20Cristescu's financial summary
• Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22C.%20Cristescu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
• How profitable is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M.%20Voicu?
• What is the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M.%20Voicu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=F.%20Cochera earns monthly
• Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22F.%20Cochera%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=P.%20Tuduce
• Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22P.%20Tuduce%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=L.%20Petrescu produce monthly?
• What's the financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22L.%20Petrescu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M.%20C.%20Tomescu earns monthly
• Check the income stats for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M.%20C.%20Tomescu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• Find out how much https://s100.copyright.com/AppDispatchServlet?title=The%20effect%20of%20candesartan%20on%20pentraxin-3%20plasma%20levels%20as%20marker%20of%20endothelial%20dysfunction%20in%20patients%20with%20essential%20arterial%20hypertension&author=V.%20Buda%20et%20al&contentID=10.1007%2Fs11845-017-1580-5©right=Royal%20Academy%20of%20Medicine%20in%20Ireland&publication=0021-1265&publicationDate=2017-02-21&publisherName=SpringerNature&orderBeanReset=true earns monthly
• What's the financial gain of https://crossmark.crossref.org/dialog/?doi=10.1007/s11845-017-1580-5?
• How much does https://citation-needed.springer.com/v2/references/10.1007/s11845-017-1580-5?format=refman&flavour=citation bring in each month?
• Discover the revenue of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral
• What is the earnings of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research?
• https://www.springernature.com/gp/products's revenue stream
• https://www.springernature.com/gp/librarians income
• Learn about the earnings of https://www.springernature.com/gp/societies
• https://www.springernature.com/gp/partners income
• What's the total monthly financial gain of https://www.springer.com/?
• Get to know https://www.nature.com/'s earnings
• Learn how profitable https://www.biomedcentral.com/ is on a monthly basis
• What's the profit of https://www.palgrave.com/?
• Get to know what's the income of https://www.apress.com/
• Learn how profitable https://www.springernature.com/gp/legal/ccpa is on a monthly basis
• How profitable is https://www.springernature.com/gp/info/accessibility?
• What's the monthly money flow for https://support.springernature.com/en/support/home?
• How much money does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations make?
• Earnings of https://www.springernature.com/

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

CDN Services {📦}

• Crossref